Last reviewed · How we verify

NCT04712318

Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile

ENROLLING BY INVITATION NA Last updated 27 August 2024
What this trial tests

NA trial testing Relex Smile in Pseudophakia in 130 participants. Enrolling by invitation.

Timeline
1 June 2016
Primary endpoint
1 June 2018
1 June 2026

Quick facts

Lead sponsorEye Hospital Pristina Kosovo
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment130
Start date1 June 2016
Primary completion1 June 2018
Estimated completion1 June 2026
Sites1 location across Kosovo

Drugs / interventions tested

Conditions studied

Sponsor

Eye Hospital Pristina Kosovo

Who can join

Adults 20 to 45, any sex, with Pseudophakia or Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Successful treatment of residual refraction 6 months after IOL Implantation with Relex-Smile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pseudophakia

Currently open trials in the same condition.

Other Eye Hospital Pristina Kosovo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04712318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing